SLEEPLESS IN AMERICA
2002 "Sleep in America" poll finds
sleep disorders on the rise in the US
random telephone sample commissioned by the National Sleep Foundation
between Oct. and Dec., 2001 with adults 18 and older found that, "73%
of respondents rated their quality of sleep as being good or better,
27% categorized it as fair or poor and 58% reported having experienced
at least one of the four symptoms of insomnia in the past year at least
a few nights a week: difficulty falling asleep,
waking up a lot during the night, waking up too early and not being
able to get back to sleep, and waking up feeling unrefreshed.
15% of respondents reported using a prescription sleep medication and/or
an over-the-counter sleep aid to help them sleep at least a few nights
a month, an increase from 11% in 2001. 37% reported that they are
so sleepy during the day that it interfered with their daily activities
a few days a month or more. 6% have taken medications to stay awake.
99% of respondents agreed that not getting enough
sleep can impair a person's performance at work, put a person at risk
for injuries or lead to health problems. 8% of respondents agreed
that not getting enough sleep can make it difficult
to get along with others. The less frequently people experience
daytime sleepiness and insomnia symptoms the more likely they are to
have a positive mood and attitude score.
whether the result of sleep disorders or sleep deprivation related to
shift work, school start times, or other social demands, has been identified
as a causal factor in a growing number of vehicular and on-the-job injuries.
Sleep deprivation is a growing problem for high school students (the
largest at-risk group for fall-asleep car crashes), parents, police
officers, and medical residents. The direct and indirect costs to the
United States economy due to sleep disorders and sleep deprivation are
estimated to exceed $100 billion each year."
Study on Deep Sleep ® aromatherapy blend planned for 2013 was canceled
Due to funding cuts, the National Institute for Health, Division of Alternative Medicine,
will only fund projects that study individual essential oils on a molecular level in a lab.
A study to test the efficacy of Deep Sleep ® aromatherapy / essential oil synergy blend is being developed by GSPI in conjunction with a medical team. The resulting data, which will be compiled by a Florida based health science college or university, is scheduled to begin in 2013. Efficacy is the capacity to produce an effect. It has different specific meanings in different fields. In medicine, it is the ability of an intervention or drug to reproduce a desired effect in expert hands and under ideal circumstances. Although not mandatory, since it is not consumed by mouth, meaning that it is not governed by the FDA, as soon as GSPI dba Just Relax, headquartered in Delray Beach, FL, raises the funds to pay for the samples, they intend to offer a 1.85 ml vial / one application of Deep Sleep ® to approximately 2,500 residents of Palm Beach, Broward and Miami-Dade Counties, Florida, who suffer from mild to chronic insomnia. The goal of the study will be to determine whether the aromatherapy formula works for at least 85% of participants. Excluded from the study will be individuals with physical conditions such as sleep apnea, psychosomatic conditions such as sleep walking, and others who have more serious and potentially life threatening conditions, such as cancer, who regularly take prescription medications which are likely to cause complications when combined with essential oils.
POB 8381, Delray Beach, FL 33482